Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (21-30 of 815) with videos related to

Pageof 82
Sort By:
Seminars in Radiation Oncology|December 8, 2014
The immunology of ablative radiationByron Burnette, Ralph R Weichselbaum
Cancer Treatment and Research|March 26, 1998
Role of gene therapy in radiation oncologyD E Hallahan, R Weichselbaum
JAMA|June 19, 1996
Radiation oncologyS Hellman, R R Weichselbaum
Lancet (London, England)|May 1, 1997
Gene therapy of cancerR R Weichselbaum, D Kufe
Hematology/Oncology Clinics of North America|June 1, 1989
Substaging of stage III Hodgkin's diseaseR Farah, R R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|January 1, 1983
Repair of potentially lethal X ray damage and possible applications to clinical radiotherapyR R Weichselbaum, J B Little
Oncology (Williston Park, N.Y.)|October 1, 1988
Treatment selection in T1 and T2 vocal cord carcinomaD J Haraf, R R Weichselbaum
Nature Clinical Practice. Oncology|July 5, 2007
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiformeRohit R Sharma, Ralph R Weichselbaum
Cell Cycle (Georgetown, Tex.)|July 21, 2017
Rhythmic radiotherapy beats down TGF-βSteven J Chmura, Ralph R Weichselbaum
The Journal of Clinical Investigation|March 2, 2026
IFN signaling at the nexus of the radiotherapy response in malignant peripheral nerve sheath tumorsSean P Pitroda, Ralph R Weichselbaum
Pageof 82

Showing results (21-30 of 815) with videos related to

Sort By:
Pageof 82
Seminars in Radiation Oncology|December 8, 2014
The immunology of ablative radiationByron Burnette, Ralph R Weichselbaum
Cancer Treatment and Research|March 26, 1998
Role of gene therapy in radiation oncologyD E Hallahan, R Weichselbaum
JAMA|June 19, 1996
Radiation oncologyS Hellman, R R Weichselbaum
Lancet (London, England)|May 1, 1997
Gene therapy of cancerR R Weichselbaum, D Kufe
Hematology/Oncology Clinics of North America|June 1, 1989
Substaging of stage III Hodgkin's diseaseR Farah, R R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|January 1, 1983
Repair of potentially lethal X ray damage and possible applications to clinical radiotherapyR R Weichselbaum, J B Little
Oncology (Williston Park, N.Y.)|October 1, 1988
Treatment selection in T1 and T2 vocal cord carcinomaD J Haraf, R R Weichselbaum
Nature Clinical Practice. Oncology|July 5, 2007
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiformeRohit R Sharma, Ralph R Weichselbaum
Cell Cycle (Georgetown, Tex.)|July 21, 2017
Rhythmic radiotherapy beats down TGF-βSteven J Chmura, Ralph R Weichselbaum
The Journal of Clinical Investigation|March 2, 2026
IFN signaling at the nexus of the radiotherapy response in malignant peripheral nerve sheath tumorsSean P Pitroda, Ralph R Weichselbaum
Pageof 82